Cell Microsystems Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$6.5M
- Investors
-
8
Cell Microsystems General Information
Description
Developer of a biological tool designed for single-cell research. The company's tools can sort and isolate single cells using the array line of consumables under standard culture conditions resulting in unperturbed phenotypes and high viability, enabling scientists to select a cell in real-time and track and trace that cell through imaging, collection, and downstream analysis as well as end-point destructive analysis of single cells for genomics.
Contact Information
Website
www.cellmicrosystems.comCorporate Office
- 801 Capitola Drive
- Suite 10
- Durham, NC 27713
- United States
Corporate Office
- 801 Capitola Drive
- Suite 10
- Durham, NC 27713
- United States
Cell Microsystems Timeline
Cell Microsystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Later Stage VC (Series B) | 28-Aug-2023 | $6.5M | Completed | Generating Revenue | ||
| 14. Later Stage VC (Series A) | 15-Nov-2021 | Completed | Generating Revenue | |||
| 13. Grant | 01-Aug-2021 | Completed | Generating Revenue | |||
| 12. Debt - PPP | 27-Jan-2021 | Completed | Generating Revenue | |||
| 11. Grant | 22-Jan-2021 | Completed | Generating Revenue | |||
| 10. Debt - General | 07-Oct-2020 | Completed | Generating Revenue | |||
| 9. Grant | 01-Aug-2020 | Completed | Generating Revenue | |||
| 8. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jan-2019 | $2.49M | $250K | Completed | Generating Revenue | |
| 6. Debt - General | 25-Sep-2018 | $250K | $250K | Completed | Generating Revenue |
Cell Microsystems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 |
Cell Microsystems Comparisons
Industry
Financing
Details
Cell Microsystems Competitors (15)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sphere Fluidics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| HiFiBiO Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| Standard BioTools | Formerly VC-backed | San Francisco, CA | ||||
| Honeycomb Biotechnologies | Venture Capital-Backed | Waltham, MA | ||||
| LumaCyte | Venture Capital-Backed | Charlottesville, VA |
Cell Microsystems Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cell Microsystems Patents
Cell Microsystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3230050-A1 | Automated system for imaging, identification, and isolation of organoids | Pending | 27-Aug-2021 | ||
| EP-4392538-A2 | Automated system for imaging, identification, and isolation of organoids | Pending | 27-Aug-2021 | ||
| JP-2024532375-A | An automated system for imaging, identification, and isolation of organoids | Pending | 27-Aug-2021 | ||
| US-20240320992-A1 | Automated system for imaging, identification, and isolation of organoids | Pending | 27-Aug-2021 | ||
| CA-3145243-A1 | Systems and methods for associating single cell imaging with rna transcriptomics | Pending | 27-Jun-2019 | C12N15/1075 |
Cell Microsystems Executive Team (3)
| Name | Title | Board Seat |
|---|---|---|
| Gary Pace Ph.D | Co-Founder, Chief Executive Officer, President & Board Member | |
| Nancy Allbritton Ph.D | Co-Founder |
Cell Microsystems Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alexander Herzick | Telegraph Hill Partners | Board Member | |
| Brett Williams | Self | Board Member | |
| Deval Lashkari Ph.D | Telegraph Hill Partners | Board Member | |
| Gary Pace Ph.D | Cell Microsystems | Co-Founder, Chief Executive Officer, President & Board Member | |
| Rob Capone | Telegraph Hill Partners | Board Member |
Cell Microsystems Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cell Microsystems Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| New Day Venture Capital | Venture Capital | Minority | ||
| Telegraph Hill Partners | Venture Capital | Minority | ||
| National Cancer Institute | Government | |||
| The National Human Genome Research Institute | Government | |||
| National Institute for Allergy and Infectious Disease | Government |
Cell Microsystems Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fluxion (Diagnostic Equipment) | 23-Aug-2023 | Diagnostic Equipment |
Cell Microsystems Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Fluxion (Diagnostic Equipment) | Diagnostic Equipment | Alameda, CA |
Cell Microsystems FAQs
-
When was Cell Microsystems founded?
Cell Microsystems was founded in 2010.
-
Who is the founder of Cell Microsystems?
Gary Pace Ph.D, Christopher Sims MD, and Nancy Allbritton Ph.D are the founders of Cell Microsystems.
-
Who is the CEO of Cell Microsystems?
Gary Pace Ph.D is the CEO of Cell Microsystems.
-
Where is Cell Microsystems headquartered?
Cell Microsystems is headquartered in Durham, NC.
-
What is the size of Cell Microsystems?
Cell Microsystems has 37 total employees.
-
What industry is Cell Microsystems in?
Cell Microsystems’s primary industry is Discovery Tools (Healthcare).
-
Is Cell Microsystems a private or public company?
Cell Microsystems is a Private company.
-
What is Cell Microsystems’s current revenue?
The current revenue for Cell Microsystems is .
-
How much funding has Cell Microsystems raised over time?
Cell Microsystems has raised $19.7M.
-
Who are Cell Microsystems’s investors?
New Day Venture Capital, Telegraph Hill Partners, National Cancer Institute, The National Human Genome Research Institute, and National Institute for Allergy and Infectious Disease are 5 of 8 investors who have invested in Cell Microsystems.
-
Who are Cell Microsystems’s competitors?
Sphere Fluidics, HiFiBiO Therapeutics, Standard BioTools, Honeycomb Biotechnologies, and LumaCyte are some of the 15 competitors of Cell Microsystems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
